Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level650 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,844 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04555304 | Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy | unknown | Phase 2 | 81 | Chengdu Kanghong Biotech Co., Ltd.INDUSTRY | 0 | Sep 18, 2020 | clinicaltrials |
| NCT04358341 | Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer | unknown | Phase 2 | 136 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Aug 24, 2020 |
| clinicaltrials |
| NCT04139070 | Electrochemotherapy for Non-curable Gastric Cancer | unknown | Phase 1 | 8 | Zealand University HospitalOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT04520295 | ctDNA Screening in Advanced HER2 Positive Gastric Cancer | unknown | — | 100 | Ruijin HospitalOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT04503967 | Efficacy and Safety of Anlotinib Hydrochloride Combined With Nivolumab in the Treatment of Gastric and Esophageal Cancer(OASIS) | unknown | Phase 2 | 48 | Shanghai Zhongshan HospitalOTHER | 0 | Aug 7, 2020 | clinicaltrials |
| NCT04501887 | The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular Profiling | unknown | — | 1,000 | Shanghai Zhongshan HospitalOTHER | 0 | Aug 6, 2020 | clinicaltrials |
| NCT03507998 | Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors | unknown | Phase 1 | 39 | Curegenix Inc.INDUSTRY | 1 | Jul 24, 2020 | clinicaltrials |
| NCT03733639 | Tisseel® as a Reinforcement of Esophagojejunal Anastomoses | unknown | Phase 4 | 146 | Germans Trias i Pujol HospitalOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT03734926 | A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors | unknown | Phase 1 | 90 | Guangdong Zhongsheng Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04443036 | Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma | unknown | N/A | 44 | China Medical University, ChinaOTHER | 1 | Jun 23, 2020 | clinicaltrials |
| NCT04440800 | Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment(WATTOX) | unknown | — | 50 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 22, 2020 | clinicaltrials |
| NCT04440605 | A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis | unknown | — | 968 | Peking UniversityOTHER | 1 | Jun 19, 2020 | clinicaltrials |
| NCT04410887 | Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC) | unknown | Phase 1 / Phase 2 | 30 | Ruijin HospitalOTHER | 1 | Jun 1, 2020 | clinicaltrials |
| NCT03478943 | The Real World Study of Apatinib for Gastric Cancer Treatment in Henan Province | unknown | — | 1,000 | Henan Cancer HospitalOTHER_GOV | 1 | May 28, 2020 | clinicaltrials |
| NCT04401124 | Status of Management of Surgery in Beijing During COVID-19 | unknown | — | 500 | Beijing Friendship HospitalOTHER | 0 | May 27, 2020 | clinicaltrials |
| NCT03046745 | Gastric Cancer Registry for Epidemiology and Molecular Risk Factor | unknown | — | 9,000 | Kyungpook National University HospitalOTHER | 1 | May 19, 2020 | clinicaltrials |
| NCT04385641 | Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer | unknown | N/A | 18 | Shandong Golden Brick Biotechnology Co., Ltd.INDUSTRY | 1 | May 13, 2020 | clinicaltrials |
| NCT02464215 | Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric Cancer(SWEET) | unknown | N/A | 440 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT04385316 | Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy | unknown | — | 3 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT04367025 | Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer | unknown | Phase 2 | 70 | Chinese PLA General HospitalOTHER | 1 | Apr 29, 2020 | clinicaltrials |
| NCT04365946 | Microbiome Analysis in Gastric Intestinal Metaplasia and in Gastric Cancer and Subtypes Correlation | unknown | — | 80 | University Hospital, IoanninaOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT03735511 | A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma | unknown | — | 270 | Henan Cancer HospitalOTHER_GOV | 1 | Apr 27, 2020 | clinicaltrials |
| NCT03817268 | Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection(CAPOGA) | unknown | Phase 3 | 768 | The First Affiliated Hospital of Anhui Medical UniversityOTHER | 1 | Apr 20, 2020 | clinicaltrials |
| NCT04152889 | A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer | unknown | Phase 2 | 20 | RenJi HospitalOTHER | 1 | Apr 20, 2020 | clinicaltrials |
| NCT04352894 | Intraoperative ICG Fluorescence Imaging for Peritoneal Carcinomatosis Detection | unknown | N/A | 120 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 0 | Apr 20, 2020 | clinicaltrials |
| NCT04351321 | The Safety of Totally Laparoscopic Versus Laparoscopy-Assisted Total Gastrectomy. | unknown | N/A | 560 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 0 | Apr 17, 2020 | clinicaltrials |
| NCT03349398 | Uncut Roux-en-Y vs Roux-en-Y | unknown | N/A | 84 | Jilin UniversityOTHER | 1 | Apr 16, 2020 | clinicaltrials |
| NCT04345770 | Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer | unknown | Phase 2 | 100 | Wuhan UniversityOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT04345783 | Efficacy and Safety of Camrelizumab for Injection, Apatinib Mesylate and Tegio for First-line Refractory Patients With Advanced Gastric Cancer | unknown | Phase 2 | 30 | Beijing Friendship HospitalOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT01978444 | Study on Laparoscopic D2 Lymphadenectomy Plus Complete Mesogastrium Excision（D2+CME）for Advanced Gastric Cancer | unknown | N/A | 169 | Huazhong University of Science and TechnologyOTHER | 1 | Apr 10, 2020 | clinicaltrials |
| NCT04327050 | Magnetic Anchoring Guided Endoscopic Submucosal Dissection for Early Gastric Caner(MAGESD) | unknown | N/A | 30 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 0 | Mar 30, 2020 | clinicaltrials |
| NCT01761461 | Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin ± Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial(ARTIST-II) | unknown | Phase 3 | 547 | Samsung Medical CenterOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT04135781 | Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer | unknown | Phase 3 | 616 | Zhejiang Cancer HospitalOTHER | 1 | Mar 23, 2020 | clinicaltrials |
| NCT01704664 | Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients | unknown | N/A | 240 | Medical University of BialystokOTHER | 1 | Mar 17, 2020 | clinicaltrials |
| NCT04194463 | Maintaining Fitness During Neo-adjuvant Chemotherapy for Oesophago-gastric Cancer: a Feasibility Study(ChemoFit) | unknown | N/A | 40 | Newcastle-upon-Tyne Hospitals NHS TrustOTHER | 1 | Mar 12, 2020 | clinicaltrials |
| NCT03264807 | Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer | unknown | Phase 3 | 518 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 3, 2020 | clinicaltrials |
| NCT04286711 | Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 52 | China Medical University, ChinaOTHER | 1 | Feb 27, 2020 | clinicaltrials |
| NCT04263870 | Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction(CTSCAPOXSEA) | unknown | Phase 2 | 36 | Sichuan UniversityOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT04065282 | The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma. | unknown | Phase 2 | 36 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Feb 10, 2020 | clinicaltrials |
| NCT04258644 | Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric Cancer | unknown | Phase 2 | 30 | Beijing Friendship HospitalOTHER | 1 | Feb 6, 2020 | clinicaltrials |
| NCT04258657 | Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer | unknown | Phase 2 | 20 | Beijing Friendship HospitalOTHER | 1 | Feb 6, 2020 | clinicaltrials |
| NCT03192735 | Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer | unknown | Phase 2 | 50 | Chang-Ming Huang, Prof.OTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT04251403 | Novel Approach to Surveillance of Gastric Lesions | unknown | Early Phase 1 | 10 | New York Presbyterian HospitalOTHER | 0 | Jan 31, 2020 | clinicaltrials |
| NCT03957564 | Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer | unknown | Phase 2 | 40 | Affiliated Hospital of Qinghai UniversityOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT03894384 | The Value of TFF3 in Diagnosis of Gastric Cancer | unknown | — | 90 | Assiut UniversityOTHER | 1 | Jan 9, 2020 | clinicaltrials |
| NCT03139487 | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism(PRIORITY) | unknown | Phase 2 | 176 | Asan Medical CenterOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT04215861 | Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy | unknown | — | 1,000 | The First Affiliated Hospital of Dalian Medical UniversityOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT03086291 | A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy | unknown | Phase 1 | 9 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 | clinicaltrials |
| NCT04066335 | Study to Evaluate the Safety of Nanoxel M Inj. | unknown | — | 1,498 | Samyang Biopharmaceuticals CorporationINDUSTRY | 1 | Dec 18, 2019 | clinicaltrials |
| NCT04202484 | Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma | unknown | Phase 2 | 20 | RenJi HospitalOTHER | 0 | Dec 17, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Sep 18, 2020source: clinicaltrials